首页 > 市场调查报告书 > 製药

眼科药物

青光眼治疗市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按药物类别、适应症、配销通路和地理位置

市场调查报告书

商品编码

1535259

青光眼治疗市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按药物类别、适应症、配销通路和地理位置

Glaucoma Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Distribution Channel, and Geography

出版日期: 2024年07月15日 | 出版商:

The Insight Partners | 英文 150 Pages | 订单完成后即时交付

价格

简介目录图表

2023年青光眼治疗市场估值为62.4亿美元，预计2031年将达80.2亿美元；预计 2023 年至 2031 年复合年增长率为 3.2%。

推动市场成长的关键因素是青光眼盛行率的不断上升、对该疾病的认识和早期诊断的提高以及产品发布的增加预计将推动市场成长。然而，药物治疗的依从性问题和高昂的治疗成本阻碍了青光眼治疗市场的成长。

青光眼治疗市场的市场趋势：

主要由于老化而导致的视神经逐渐损伤（通常与眼内高压（眼内压）有关）会导致一组称为青光眼的眼部疾病，最终导致不可逆的失明。青光眼最常见的治疗方法之一是使用眼药水降低眼内压。然而，患者坚持使用这些眼药水可能具有挑战性，患者教育不足可能会阻碍治疗成功。此外，降眼压药物可能引起局部和全身副作用，可能使治疗更加复杂。人们日益关注开发具有更高稳定性、更长循环时间和有针对性的结合特性的改进配方，这可能会为市场带来新产品。青光眼治疗的最新进展彻底改变了市场上可用的治疗方法。使用具有合适结构和优异结合能力的奈米颗粒有利于药物的生物利用度和功效。与传统眼药水相比，缓释 (SR) 植入物和其他创新药物传递系统可提高患者依从性并减少副作用。多家公司正在开发 SR 药物输送系统，作为局部给药的替代方案，以潜在克服治疗 POAG 的障碍。根据 2022 年 PubMed Central 发表的文章，美国食品药物管理局 (FDA) 唯一批准的 POAG SR 疗法是 Allergan plc 的 Bimatoprost SR (DurystaTM)。其他SR 疗法包括比马前列素眼环(Allergan)、iDose (Glaukos Corporation)、ENV515 (Envisia Therapeutics)、OTX-TP (Oural Therapeutix)、OTX-TIC (Oural Therapeutix) 和拉坦前列素游离酸SR (SR ( PolyActiva) 正在研究中。 POAG 管理中的 SR 给药技术可能会改变治疗模式并显着改善结果。因此，新型药物传输方法和联合疗法的开发可能仍然是青光眼治疗市场的主要趋势。

青光眼治疗市场：细分概述

青光眼治疗市场根据药物类别、适应症和配销通路进行细分。

依药物类别，市场分为β受体阻断剂、α-肾上腺素激动剂、前列腺素类似物、碳酸酐酶抑制剂、合併药物等。到2023年，前列腺素类似物细分市场将占据更大的市场份额。它们每天给药一次，可显着降低眼压，全身副作用较低。因此，前列腺素类似物的好处是青光眼治疗市场规模扩大的原因。

依适应症，市场分为开角型青光眼、闭角型青光眼等。开角型青光眼细分市场在 2023 年占据最大的青光眼治疗市场份额，预计 2023 年至 2031 年复合年增长率最高。最初，它没有表现出任何症状。然而，在某些时候，一个人可能会在不接受治疗的情况下开始失去侧面（週边）视力，导致完全失明。

依配销通路，市场分为医院药房、零售药房和网路药房。 2023年，医院药局领域占据市场主导地位。

青光眼治疗市场：地理概况

青光眼治疗市场报告的范围涉及北美（美国、加拿大和墨西哥）、欧洲（西班牙、英国、德国、法国、义大利和欧洲其他地区）、亚太地区（韩国、中国、印度）、日本、澳洲和亚太其他地区）、中东和非洲（南非、沙乌地阿拉伯、阿联酋以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和其他地区）南美洲和中美洲）。预计从2023 年到2031 年，亚太地区的复合年增长率将是市场上最快的。正在进行的开发新型青光眼疗法的临床研究以及该地区医疗保健支出的增加等因素将促进亚太地区青光眼治疗市场的增长。就收入而言，北美在 2023 年占据最大的青光眼治疗市场。

青光眼治疗市场 - 主要市场动态
市场驱动因素
- 青光眼疾病的发生率不断上升
- 产品发布、合作、收购数量不断增加
市场限制
- 用药方案合规性问题
市场机会
- 穿戴式科技的发展
未来趋势
- 新型药物输送方法的开发
驱动因素和限制的影响：

第 6 章：青光眼治疗市场 - 全球市场分析

青光眼治疗市场收入，2021-2031
青光眼治疗市场预测分析

第 7 章：青光眼治疗市场分析 - 按药物类别

β受体阻断剂
α肾上腺素激动剂
前列腺素类似物
碳酸酐酶抑制剂
复方药物
其他的

第 8 章：青光眼治疗市场分析 - 按适应症

开角型青光眼
闭角型青光眼
其他的

第 9 章：青光眼治疗市场分析 - 按配销通路

医院药房
零售药房
网路药房

第 10 章：青光眼治疗市场 - 地理分析

北美洲
- 美国
- 加拿大
- 墨西哥
欧洲
- 德国
- 法国
- 英国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿拉伯聯合大公国
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 11 章：青光眼治疗市场 - 产业格局

青光眼治疗市场的成长策略
有机成长策略
- 概述
无机成长策略
- 概述

第 12 章：公司简介

Alcon AG
AbbVie Inc
Bausch & Lomb Inc
Fera Pharmaceuticals, LLC
Viatris Inc
Novartis AG
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Thea Pharma Inc
Santen Pharmaceutical Co., Ltd.

第 13 章：附录

简介目录图表

Product Code: TIPRE00018828

The glaucoma therapeutics market was valued at US$ 6.24 billion in 2023 and is expected to reach US$ 8.02 billion by 2031; it is estimated to record a CAGR of 3.2% during 2023-2031.

Key factors driving the market growth are the growing prevalence of glaucoma, rising awareness and early diagnosis of the disease, and increasing product launches are expected to drive the market growth. However, compliance issues with medication regimens and the high cost of treatments hinder the glaucoma therapeutics market growth.

Market Trends of the Glaucoma Therapeutics Market:

The gradual damage of the optic nerve-typically associated with high pressure inside the eye (intraocular pressure)-predominantly due to aging can lead to a group of eye diseases called Glaucoma, which can eventually result in irreversible blindness. One of the most common treatments for glaucoma is to reduce intraocular pressure by using eye drops. However, patient adherence to these eye drops can be challenging, and inadequate patient education can impede treatment success. Additionally, ocular hypotensive drugs can cause local and systemic side effects that may further complicate the treatment. Rising focus on the development of improved formulations with enhanced stability, longer circulation times, and targeted binding properties is likely to add novel products to the market. Recent advancements in glaucoma therapeutics have revolutionized the available treatments in the market. The use of nanoparticles with suitable structures and superior binding capabilities facilitates the bioavailability and efficacy of the drug. Sustained-release (SR) implants and other innovative drug delivery systems offer improved patient compliance and reduced side effects compared to conventional eye drops. Several companies are developing SR drug delivery systems as an alternative to topical delivery to potentially overcome barriers in treating POAG. As per the article published in PubMed Central in 2022, the only approved SR therapy for POAG by the Food and Drug Administration (FDA) is Bimatoprost SR (DurystaTM) from Allergan plc. Other SR therapies including bimatoprost ocular ring (Allergan), iDose (Glaukos Corporation), ENV515 (Envisia Therapeutics), OTX-TP (Ocular Therapeutix), OTX-TIC (Ocular Therapeutix), and latanoprost free acid SR (PolyActiva) are under investigation. SR drug delivery technology in POAG management may shift treatment paradigms and dramatically improve outcomes. Therefore, the development of novel drug delivery methods and combination therapies is likely to remain a key trend in the glaucoma therapeutics market.

Glaucoma therapeutics Market: Segmental Overview

The glaucoma therapeutics market is segmented on the basis of drug class, indication, and distribution channel.

By drug class, the market is divided into beta blockers, alpha-adrenergic agonists, prostaglandin analogs, carbonic anhydrase inhibitors, combination drugs, and others. The prostaglandin analogs segment held a larger market share in 2023. Prostaglandin analogs are the first-line treatment for high intraocular pressure in glaucoma patients. They offer a once-a-day dosing, a significant reduction in intraocular pressure, and low systemic side effects. Thus, the benefits of prostaglandin analogs are responsible for the expansion of the glaucoma therapeutics market size.

The market, by indication, is segmented into open angle glaucoma, angle closure glaucoma, and others. The open-angle glaucoma segment held the largest glaucoma therapeutics market share in 2023 and is projected to register the highest CAGR from 2023 to 2031. Open-angle glaucoma is the most common form of glaucoma, which affects approximately 95% of individuals. Initially, it does not show any symptoms. However, at some point, an individual may start losing their side (peripheral) vision without treatment, resulting in total blindness.

By distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the market in 2023.

Glaucoma therapeutics Market: Geographical Overview

The scope of the glaucoma therapeutics market report entails North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Asia Pacific is expected to register the fastest CAGR in the market from 2023 to 2031. Factors such as ongoing clinical studies for developing novel glaucoma therapies, as well as increasing healthcare expenditures in the region, contribute to the glaucoma therapeutics market growth in Asia Pacific. In terms of revenue, North America accounted for the largest glaucoma therapeutics market share in 2023.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Glaucoma Therapeutics Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Glaucoma Therapeutics Market - Key Market Dynamics

5.1 Glaucoma Therapeutics Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Mounting Incidence of Glaucoma Disease
- 5.2.2 Increasing Number of Product Launches, Collaborations, Acquisitions
5.3 Market Restraints
- 5.3.1 Medication Regimen Compliance Issues
5.4 Market Opportunities
- 5.4.1 Development of Wearable Technologies
5.5 Future Trends
- 5.5.1 Development of Novel Drug Delivery Methods
5.6 Impact of Drivers and Restraints:

6. Glaucoma Therapeutics Market - Global Market Analysis

6.1 Glaucoma Therapeutics Market Revenue (US$ Million), 2021-2031
6.2 Glaucoma Therapeutics Market Forecast Analysis

7. Glaucoma Therapeutics Market Analysis - by Drug Class

7.1 Beta Blockers
- 7.1.1 Overview
- 7.1.2 Beta Blockers: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Alpha Adrenergic Agonists
- 7.2.1 Overview
- 7.2.2 Alpha Adrenergic Agonists: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Prostaglandins Analogues
- 7.3.1 Overview
- 7.3.2 Prostaglandins Analogues: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Carbonic Anhydrase Inhibitors
- 7.4.1 Overview
- 7.4.2 Carbonic Anhydrase Inhibitors: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Combination Drugs
- 7.5.1 Overview
- 7.5.2 Combination Drugs: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

8. Glaucoma Therapeutics Market Analysis - by Indication

8.1 Open Angle Glaucoma
- 8.1.1 Overview
- 8.1.2 Open Angle Glaucoma: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Angle Closure Glaucoma
- 8.2.1 Overview
- 8.2.2 Angle Closure Glaucoma: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

9. Glaucoma Therapeutics Market Analysis - by Distribution Channel

9.1 Hospital Pharmacy
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Retail Pharmacy
- 9.2.1 Overview
- 9.2.2 Retail Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Online Pharmacy
- 9.3.1 Overview
- 9.3.2 Online Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

10. Glaucoma Therapeutics Market - Geographical Analysis

10.1 Overview
10.2 North America
- 10.2.1 North America Glaucoma Therapeutics Market Overview
- 10.2.2 North America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.3 North America: Glaucoma Therapeutics Market Breakdown, by Drug Class
  - 10.2.3.1 North America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Drug Class
- 10.2.4 North America: Glaucoma Therapeutics Market Breakdown, by Indication
  - 10.2.4.1 North America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Indication
- 10.2.5 North America: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.2.5.1 North America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.2.6 North America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.2.6.1 North America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.2.6.2 United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.6.2.1 United States: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.2.6.2.2 United States: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.2.6.2.3 United States: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.2.6.3 Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.6.3.1 Canada: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.2.6.3.2 Canada: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.2.6.3.3 Canada: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.2.6.4 Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.6.4.1 Mexico: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.2.6.4.2 Mexico: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.2.6.4.3 Mexico: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
10.3 Europe
- 10.3.1 Europe Glaucoma Therapeutics Market Overview
- 10.3.2 Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.3 Europe: Glaucoma Therapeutics Market Breakdown, by Drug Class
  - 10.3.3.1 Europe: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Drug Class
- 10.3.4 Europe: Glaucoma Therapeutics Market Breakdown, by Indication
  - 10.3.4.1 Europe: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Indication
- 10.3.5 Europe: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.3.5.1 Europe: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.3.6 Europe: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.3.6.1 Europe: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.3.6.2 Germany: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.2.1 Germany: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.3.6.2.2 Germany: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.3.6.2.3 Germany: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.3.6.3 France: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.3.1 France: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.3.6.3.2 France: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.3.6.3.3 France: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.3.6.4 United Kingdom: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.4.1 United Kingdom: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.3.6.4.2 United Kingdom: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.3.6.4.3 United Kingdom: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.3.6.5 Italy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.5.1 Italy: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.3.6.5.2 Italy: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.3.6.5.3 Italy: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.3.6.6 Spain: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.6.1 Spain: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.3.6.6.2 Spain: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.3.6.6.3 Spain: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.3.6.7 Rest of Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.7.1 Rest of Europe: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.3.6.7.2 Rest of Europe: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.3.6.7.3 Rest of Europe: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
10.4 Asia Pacific
- 10.4.1 Asia Pacific Glaucoma Therapeutics Market Overview
- 10.4.2 Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.3 Asia Pacific: Glaucoma Therapeutics Market Breakdown, by Drug Class
  - 10.4.3.1 Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Drug Class
- 10.4.4 Asia Pacific: Glaucoma Therapeutics Market Breakdown, by Indication
  - 10.4.4.1 Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Indication
- 10.4.5 Asia Pacific: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.4.5.1 Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.4.6 Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.4.6.1 Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.4.6.2 China: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.2.1 China: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.4.6.2.2 China: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.4.6.2.3 China: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.4.6.3 Japan: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.3.1 Japan: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.4.6.3.2 Japan: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.4.6.3.3 Japan: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.4.6.4 India: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.4.1 India: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.4.6.4.2 India: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.4.6.4.3 India: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.4.6.5 Australia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.5.1 Australia: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.4.6.5.2 Australia: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.4.6.5.3 Australia: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.4.6.6 South Korea: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.6.1 South Korea: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.4.6.6.2 South Korea: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.4.6.6.3 South Korea: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.4.6.7 Rest of APAC: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.7.1 Rest of APAC: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.4.6.7.2 Rest of APAC: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.4.6.7.3 Rest of APAC: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Glaucoma Therapeutics Market Overview
- 10.5.2 Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.3 Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Drug Class
  - 10.5.3.1 Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Drug Class
- 10.5.4 Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Indication
  - 10.5.4.1 Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Indication
- 10.5.5 Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.5.5.1 Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.5.6 Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.5.6.1 Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.5.6.2 Saudi Arabia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.6.2.1 Saudi Arabia: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.5.6.2.2 Saudi Arabia: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.5.6.2.3 Saudi Arabia: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.5.6.3 South Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.6.3.1 South Africa: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.5.6.3.2 South Africa: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.5.6.3.3 South Africa: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.5.6.4 United Arab Emirates: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.6.4.1 United Arab Emirates: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.5.6.4.2 United Arab Emirates: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.5.6.4.3 United Arab Emirates: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.5.6.5 Rest of Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.6.5.1 Rest of Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.5.6.5.2 Rest of Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.5.6.5.3 Rest of Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
10.6 South and Central America
- 10.6.1 South and Central America Glaucoma Therapeutics Market Overview
- 10.6.2 South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.3 South and Central America: Glaucoma Therapeutics Market Breakdown, by Drug Class
  - 10.6.3.1 South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Drug Class
- 10.6.4 South and Central America: Glaucoma Therapeutics Market Breakdown, by Indication
  - 10.6.4.1 South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Indication
- 10.6.5 South and Central America: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.6.5.1 South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.6.6 South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.6.6.1 South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country
  - 10.6.6.2 Brazil: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.6.2.1 Brazil: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.6.6.2.2 Brazil: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.6.6.2.3 Brazil: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.6.6.3 Argentina: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.6.3.1 Argentina: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.6.6.3.2 Argentina: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.6.6.3.3 Argentina: Glaucoma Therapeutics Market Breakdown, by Distribution Channel
  - 10.6.6.4 Rest of South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.6.4.1 Rest of South and Central America: Glaucoma Therapeutics Market Breakdown, by Drug Class
    - 10.6.6.4.2 Rest of South and Central America: Glaucoma Therapeutics Market Breakdown, by Indication
    - 10.6.6.4.3 Rest of South and Central America: Glaucoma Therapeutics Market Breakdown, by Distribution Channel

11. Glaucoma Therapeutics Market - Industry Landscape

11.1 Growth Strategies in Glaucoma Therapeutics Market
11.2 Organic Growth Strategies
- 11.2.1 Overview
11.3 Inorganic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Alcon AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AbbVie Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bausch & Lomb Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Fera Pharmaceuticals, LLC
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Viatris Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Novartis AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Sun Pharmaceutical Industries Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Teva Pharmaceutical Industries Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thea Pharma Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Santen Pharmaceutical Co., Ltd.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Glaucoma Therapeutics Market Segmentation
Table 2. Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Class
Table 4. Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Indication
Table 5. Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 6. North America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 7. North America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 8. North America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 9. North America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 10. United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 11. United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 12. United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 13. Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 14. Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 15. Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 16. Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 17. Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 18. Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 19. Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 20. Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 21. Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 22. Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 23. Germany: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 24. Germany: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 25. Germany: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 26. France: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 27. France: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 28. France: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 29. United Kingdom: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 30. United Kingdom: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 31. United Kingdom: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 32. Italy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 33. Italy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 34. Italy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 35. Spain: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 36. Spain: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 37. Spain: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 38. Rest of Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 39. Rest of Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 40. Rest of Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 41. Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 42. Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 43. Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 44. Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 45. China: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 46. China: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 47. China: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 48. Japan: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 49. Japan: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 50. Japan: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 51. India: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 52. India: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 53. India: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 54. Australia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 55. Australia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 56. Australia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 57. South Korea: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 58. South Korea: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 59. South Korea: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 60. Rest of APAC: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 61. Rest of APAC: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 62. Rest of APAC: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 63. Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 64. Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 65. Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 66. Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 67. Saudi Arabia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 68. Saudi Arabia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 69. Saudi Arabia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 70. South Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 71. South Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 72. South Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 73. United Arab Emirates: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 74. United Arab Emirates: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 75. United Arab Emirates: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 76. Rest of Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 77. Rest of Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 78. Rest of Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 79. South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 80. South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 81. South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 82. South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 83. Brazil: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 84. Brazil: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 85. Brazil: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 86. Argentina: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 87. Argentina: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 88. Argentina: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 89. Rest of South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 90. Rest of South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Indication
Table 91. Rest of South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 92. Recent Organic Growth Strategies in Glaucoma Therapeutics Market
Table 93. Recent Inorganic Growth Strategies in the Glaucoma Therapeutics Market
Table 94. Glossary of Terms, Transiaent Protein Expression Market

List Of Figures

Figure 1. Glaucoma Therapeutics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Glaucoma Therapeutics Market Revenue (US$ Million), 2021-2031
Figure 5. Glaucoma Therapeutics Market Share (%) - by Drug Class (2023 and 2031)
Figure 6. Beta Blockers: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Alpha Adrenergic Agonists: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Prostaglandins Analogues: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Carbonic Anhydrase Inhibitors: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Combination Drugs: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Glaucoma Therapeutics Market Share (%) - by Indication (2023 and 2031)
Figure 13. Open Angle Glaucoma: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Angle Closure Glaucoma: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Glaucoma Therapeutics Market Share (%) - by Distribution Channel (2023 and 2031)
Figure 17. Hospital Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Retail Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Online Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Glaucoma Therapeutics Market Breakdown by Region, 2023 and 2031 (%)
Figure 21. North America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. North America: Glaucoma Therapeutics Market Breakdown, by Drug Class (2023 and 2031)
Figure 23. North America: Glaucoma Therapeutics Market Breakdown, by Indication (2023 and 2031)
Figure 24. North America: Glaucoma Therapeutics Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 25. North America: Glaucoma Therapeutics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 29. Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 30. Europe: Glaucoma Therapeutics Market Breakdown, by Drug Class (2023 and 2031)
Figure 31. Europe: Glaucoma Therapeutics Market Breakdown, by Indication (2023 and 2031)
Figure 32. Europe: Glaucoma Therapeutics Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 33. Europe: Glaucoma Therapeutics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. Germany: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. France: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 36. United Kingdom: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 37. Italy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 38. Spain: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 39. Rest of Europe: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 40. Asia Pacific: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. Asia Pacific: Glaucoma Therapeutics Market Breakdown, by Drug Class (2023 and 2031)
Figure 42. Asia Pacific: Glaucoma Therapeutics Market Breakdown, by Indication (2023 and 2031)
Figure 43. Asia Pacific: Glaucoma Therapeutics Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 44. Asia Pacific: Glaucoma Therapeutics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 45. China: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 46. Japan: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 47. India: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 48. Australia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 49. South Korea: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 50. Rest of APAC: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 51. Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 52. Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Drug Class (2023 and 2031)
Figure 53. Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Indication (2023 and 2031)
Figure 54. Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 55. Middle East and Africa: Glaucoma Therapeutics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 56. Saudi Arabia: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 57. South Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 58. United Arab Emirates: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 59. Rest of Middle East and Africa: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 60. South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 61. South and Central America: Glaucoma Therapeutics Market Breakdown, by Drug Class (2023 and 2031)
Figure 62. South and Central America: Glaucoma Therapeutics Market Breakdown, by Indication (2023 and 2031)
Figure 63. South and Central America: Glaucoma Therapeutics Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 64. South and Central America: Glaucoma Therapeutics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 65. Brazil: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 66. Argentina: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 67. Rest of South and Central America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031(US$ Million)
Figure 68. Growth Strategies in Glaucoma Therapeutics Market

02-2729-4219

+886-2-2729-4219

License/价格

青光眼治疗市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按药物类别、适应症、配销通路和地理位置

Glaucoma Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Distribution Channel, and Geography

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

第 4 章：青光眼治疗市场格局

第 5 章：青光眼治疗市场 - 主要市场动态

第 6 章：青光眼治疗市场 - 全球市场分析

第 7 章：青光眼治疗市场分析 - 按药物类别

第 8 章：青光眼治疗市场分析 - 按适应症

第 9 章：青光眼治疗市场分析 - 按配销通路

第 10 章：青光眼治疗市场 - 地理分析

第 11 章：青光眼治疗市场 - 产业格局

第 12 章：公司简介

第 13 章：附录

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Glaucoma Therapeutics Market Landscape

5. Glaucoma Therapeutics Market - Key Market Dynamics

6. Glaucoma Therapeutics Market - Global Market Analysis

7. Glaucoma Therapeutics Market Analysis - by Drug Class

8. Glaucoma Therapeutics Market Analysis - by Indication

9. Glaucoma Therapeutics Market Analysis - by Distribution Channel

10. Glaucoma Therapeutics Market - Geographical Analysis

11. Glaucoma Therapeutics Market - Industry Landscape

12. Company Profiles

13. Appendix

List Of Tables

List Of Figures